Development
Predictmedix AI Inc.
PMED
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -37.70% | -36.41% | -18.11% | -4.43% | 8.56% |
| Total Depreciation and Amortization | -10.61% | 10.61% | -84.80% | 114.39% | 1,400.00% |
| Total Amortization of Deferred Charges | -21.02% | -1.36% | 137.04% | 89.47% | -- |
| Total Other Non-Cash Items | 216.79% | 513.65% | 273.75% | 121.31% | -67.00% |
| Change in Net Operating Assets | -93.61% | -135.64% | 42.30% | 1,604.96% | 374.00% |
| Cash from Operations | -161.39% | -108.55% | 19.95% | 66.90% | 61.94% |
| Capital Expenditure | 68.43% | 68.43% | 68.43% | -8.67% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.78% | 92.37% | 91.08% | 85.62% | 46.66% |
| Cash from Investing | 81.40% | 82.16% | 84.33% | 66.73% | 3.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 205.55% | 480.98% | 1,707.50% | -56.91% | -57.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 88.15% | 27.57% | 85.97% | -111.36% | -120.90% |
| Cash from Financing | 254.89% | 567.17% | -- | -68.77% | -74.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.95% | 92.76% | 100.89% | 55.48% | -227.44% |